pubmed-article:15354638 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C0005779 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C0040018 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C0332237 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C1522168 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:15354638 | lifeskim:mentions | umls-concept:C0456904 | lld:lifeskim |
pubmed-article:15354638 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15354638 | pubmed:dateCreated | 2004-9-9 | lld:pubmed |
pubmed-article:15354638 | pubmed:abstractText | This report describes a case of severe coagulopathy and bleeding related to the intraoperative use of topically applied thrombin. Commercial thrombin preparations contaminated with bovine factor V have been shown to stimulate the production of antibodies directed against factor V. These antibodies can cause coagulopathy. Our patient developed antibodies against factor V after intraoperative exposure to topical thrombin. The resulting antibody-mediated depletion of factor V caused a severe and refractory coagulopathy. Vascular surgeons should be aware that the use of topical bovine thrombin can cause severe coagulopathy. | lld:pubmed |
pubmed-article:15354638 | pubmed:language | eng | lld:pubmed |
pubmed-article:15354638 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15354638 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15354638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15354638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15354638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15354638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15354638 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15354638 | pubmed:month | May | lld:pubmed |
pubmed-article:15354638 | pubmed:issn | 0890-5096 | lld:pubmed |
pubmed-article:15354638 | pubmed:author | pubmed-author:SarfatiMark... | lld:pubmed |
pubmed-article:15354638 | pubmed:author | pubmed-author:GaltSpencer... | lld:pubmed |
pubmed-article:15354638 | pubmed:author | pubmed-author:KraissLarry... | lld:pubmed |
pubmed-article:15354638 | pubmed:author | pubmed-author:DilorenzoDani... | lld:pubmed |
pubmed-article:15354638 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15354638 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:15354638 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15354638 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15354638 | pubmed:pagination | 349-51 | lld:pubmed |
pubmed-article:15354638 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:meshHeading | pubmed-meshheading:15354638... | lld:pubmed |
pubmed-article:15354638 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15354638 | pubmed:articleTitle | Severe coagulopathy following intraoperative use of topical thrombin. | lld:pubmed |
pubmed-article:15354638 | pubmed:affiliation | Division of Vascular Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84103, USA. mark.sarfati@hsc.utah.edu | lld:pubmed |
pubmed-article:15354638 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15354638 | pubmed:publicationType | Case Reports | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15354638 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15354638 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15354638 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15354638 | lld:pubmed |